← Eichor
Study identifier: NCT05971537 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Clinical Trial on Antibiotic-Lock in Tenckhoff Catheter for Relasping and Repeat Peritonitis

Condition: Peritoneal Dialysis-associated Peritonitis  ·  Sponsor: Alice Ho Miu Ling Nethersole Hospital

PhasePhase 4
Planned participants46
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Biofilm formation is an important cause of catheter-related infection. In hemodialysis, use of an antibiotic-lock has been proven to be effective to manage such a complication with preservation of the central venous catheter. In peritoneal dialysis, while biofilm has been implicated in relapsing and repeat peritonitis, both of which are caused by the identical bacteria as in their preceding peritonitis episode, no adjunctive measure has been proven to be effective to eradicate the biofilm bacteria. As a result, Tenckhoff catheter removal is the only recommended option for the patients suffering from relapsing or repeat peritonitis. In this study, the investigators are going to investigate whether the use of an antibiotic-lock can be useful to eradicate the biofilm in the Tenckhoff catheter to prevent future episodes of peritonitis caused by the same organism.

This description comes directly from the study's public registry record.

Talk to the study team

Ping Kwan Chan  ·  26892000  ·  cpk618a@ha.org.hk

Always discuss trial participation with your own doctor first.

Locations (1)

Alice Ho Miu Ling Nethersole HospitalTai Po, Hong KongRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05971537